Compass Capital Corp »

Alnylam Pharmaceuticals shares owned by Compass Capital Corp

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Compass Capital Corp from 13F filings

Historical chart of Compass Capital Corp investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Compass Capital Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Compass Capital Corp

Quarter filed Position value Share count Share price at filing
2025-09-30 $353k 800 441.70
2025-06-30 $254k 800 318.01
2025-03-31 $215k 800 268.76
2024-12-31 $210k 800 263.04

More positions owned by Compass Capital Corp

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Admiral Fds 500 Grth Idx F (VOOG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Palantir Technologies Cl A (PLTR)
Sei Exchange Traded Funds Select Intl Equi (SEIE)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)

View all positions for Compass Capital Corp

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals